Life
FDA Urges Drugmakers to Address Unreported Clinical Trial Results
An FDA analysis reveals that almost 30% of clinical trials, likely subject to mandatory reporting, have not submitted their results, prompting calls for accountability from drug manufacturers.
editorial-staff Apr 13